INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC FORM 432m ago
HOUSE PTR32m ago
SEC 13F32m ago
ROBINHOOD CHAIN31m ago

Results

8,512 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
55
RE
Rodriguez EnriqueEVP, Chief Technology Officer
LBTYLiberty Global Ltd.
Open-market purchase
BUY$2.00M
211.3K sh
Nov 4, 2026
Page 1 of 213
Next →
Nov 5, 2026
traded Nov 4, 2026
+1d
SEC FORM 4

Evidence

47
FT
Fries Michael TDirector, President & CEO
LBTYLiberty Global Ltd.
Open-market purchase
BUY$1.03M
110.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC FORM 4

Evidence

40
TS
Talbot SiobhanDirector
CRHCRH PUBLIC LTD CO
Open-market purchase
BUY$189K
2,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

39
MR
Magow RajeshDirector, Group Chief Executive Officer
MMYTMakeMyTrip Ltd
Open-market sale
SELL$905K
20.0K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

38
SA
Schulten AndreChief Financial Officer
PGPROCTER & GAMBLE Co
Open-market sale
SELL$5.55M
33.6K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC FORM 4

Evidence

35
MR
Magow RajeshDirector, Group Chief Executive Officer
MMYTMakeMyTrip Ltd
Open-market sale
SELL$501K
10.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC FORM 4

Evidence

32
DI
Donegal Mutual Insurance Co10% Owner
DGICADONEGAL GROUP INC
Open-market purchase
BUY$140K
7,500 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

62
MP
Marino Glenn PDirector
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$393K
17.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

59
LM
Langenstein MollyDirector
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$50K
2,186 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

55
WR
Wooters RebeccaEVP, Chief Growth Officer
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$99K
4,325 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

54
KH
Khouri HalimEVP, Chief Financial Officer
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$251K
11.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

54
BJ
Brown Jeffrey JDirector
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$400K
17.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

51
PA
Partners Group Finance (USD) AGAffiliate of the Adviser
NAPartners Group Growth, LLC
Open-market purchase
BUY$19.98M
9.51M sh
Nov 1, 2026Nov 4, 2026
traded Nov 1, 2026
+3dSEC FORM 4

Evidence

51
KB
Kumar BalajiEVP, Chief Technology Officer
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$50K
2,200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

49
WL
Way T LawrenceDirector
CUBICustomers Bancorp, Inc.
Open-market sale
SELL$4.09M
48.8K sh
Oct 30, 2026Nov 4, 2026
traded Oct 30, 2026
+5dSEC FORM 4

Evidence

48
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$6.83M
7,073 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

47
SA
Shepherd Brian A.Director
LRNStride, Inc.
Open-market purchase
BUY$375K
4,880 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

47
SA
Shepherd Brian A.Director
LRNStride, Inc.
Open-market purchase
BUY$545K
7,120 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

45
MM
Manley Michael MarkDirector, CEO and Director
ANAUTONATION, INC.
Open-market purchase
BUY$349K
1,892 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

45
MM
Manley Michael MarkDirector, CEO and Director
ANAUTONATION, INC.
Open-market purchase
BUY$682K
3,708 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$3.80M
3,939 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.47M
1,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.58M
2,670 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$4.18M
4,338 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.43M
2,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
ZF
Zuberbuhler Adolfo FernandoChief Financial Officer
PAMPampa Energy Inc.
Open-market purchase
BUY$207K
3,136 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

43
TE
Tryniski Mark EDirector
TBBKBancorp, Inc.
Open-market purchase
BUY—
5,000 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

43
TF
Tamer FordDirector, President & CEO
LSCCLATTICE SEMICONDUCTOR CORP
Open-market purchase
BUY$585K
5,696 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

43
TF
Tamer FordDirector, President & CEO
LSCCLATTICE SEMICONDUCTOR CORP
Open-market purchase
BUY$295K
2,894 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

42
MM
Murphy Robert MadisonDirector
MUSAMurphy USA Inc.
Open-market sale
SELL$589K
1,000 sh
May 4, 2026Nov 4, 2026
traded May 4, 2026
+184dSEC FORM 4

Evidence

42
EC
Edmunds C ColemanEVP, Gen Counsel & Corp Sec
ANAUTONATION, INC.
Open-market purchase
BUY$55K
300 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

42
SM
Skeete Bernard MChief Accounting Officer
VLTOVeralto Corp
Open-market sale
SELL$170K
1,514 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

42
SA
Szlosek Thomas AEVP & CFO
ANAUTONATION, INC.
Open-market purchase
BUY$100K
551 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

41
KE
Kowaleski John E.Director
GLVClough Global Dividend & Income Fund
Open-market purchase
BUY$4,050
700 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

41
KE
Kowaleski John E.Director
GLQClough Global Equity Fund
Open-market purchase
BUY$1,966
260 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

41
KE
Kowaleski John E.Director
GLOClough Global Opportunities Fund
Open-market purchase
BUY$1,997
365 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

40
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.18M
1,224 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.01M
1,040 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
WD
Wang Mark DDirector, See Remarks
HGVHilton Grand Vacations Inc.
Open-market purchase
BUY$499K
12.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
PM
Pope Daniel MDirector
TYLTYLER TECHNOLOGIES INC
Open-market sale
SELL$277K
680 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence